39108 Federal Register / Vol. 83, No. 153 / Wednesday, August 8, 2018 / Notices 

as amended. The grant applications 

and/or contract proposals and the 

discussions could disclose confidential 

trade secrets or commercial property 

such as patentable material, and 

personal information concerning 

individuals associated with the grant 

applications and/or contract proposals, 

the disclosure of which would 

constitute a clearly unwarranted 

invasion of personal privacy. 

Name of Committee: National Advisory 

Council on Minority Health and Health 

Disparities. 

Date: September 6–7, 2018. 

Closed: September 6, 2018, 1:30 p.m. to 

adjournment. 

Agenda: To review and evaluate grant 

applications and/or proposals. 

Place: National Institutes of Health, 

Natcher Building, 45 Center Drive, 

Conference Rooms E1 and E2, Bethesda, MD 

20892. 

Open: September 7, 2018, 8:00 a.m. to 

12:00 p.m. 

Agenda: The agenda will include opening 

remarks, administrative matters, Director’s 

report, NIH Health Disparities update, and 

other business of the Council. 

Place: National Institutes of Health, 

Natcher Building, 45 Center Drive, 

Conference Rooms E1 and E2, Bethesda, MD 

20892. 

Contact Person: Dr. Joyce A. Hunter, 

Deputy Director, NIMHD, National Institutes 

of Health, National Institute on Minority 

Health and Heath Disparities, 6707 

Democracy Blvd., Suite 800, Bethesda, MD 

20892, (301) 402–1366, hunterj@nih.gov. 

Any member of the public interested in 

presenting oral comments to the committee 

may notify the Contact Person listed on this 

notice at least 10 days in advance of the 

meeting. Interested individuals and 

representatives of organizations may submit 

a letter of intent, a brief description of the 

organization represented, and a short 

description of the oral presentation. Only one 

representative of an organization may be 

allowed to present oral comments and if 

accepted by the committee, presentations 

may be limited to five minutes. Both printed 

and electronic copies are requested for the 

record. In addition, any interested person 

may file written comments with the 

committee by forwarding their statement to 

the Contact Person listed on this notice. The 

statement should include the name, address, 

telephone number and when applicable, the 

business or professional affiliation of the 

interested person. 

In the interest of security, NIH has 

instituted stringent procedures for entrance 

onto the NIH campus. 

All visitor vehicles, including taxis, hotel, 

and airport shuttles, will be inspected before 

being allowed on campus. Visitors will be 

asked to show one form of identification (for 

example, a government-issued photo ID, 

driver’s license, or passport) and to state the 

purpose of their visit. 

Dated: August 2, 2018. 

David D. Clary, 

Program Analyst, Office of Federal Advisory 

Committee Policy. 

[FR Doc. 2018–16976 Filed 8–7–18; 8:45 am] 

BILLING CODE 4140–01–P 

DEPARTMENT OF HEALTH AND 

HUMAN SERVICES 

National Institutes of Health 

National Institute of Arthritis and 

Musculoskeletal and Skin Diseases; 

Notice of Meeting 

Pursuant to section 10(d) of the 

Federal Advisory Committee Act, as 

amended, notice is hereby given of a 

meeting of the National Arthritis and 

Musculoskeletal and Skin Diseases 

Advisory Council. 

The meeting will be open to the 

public as indicated below, with 

attendance limited to space available. 

Individuals who plan to attend and 

need special assistance, such as sign 

language interpretation or other 

reasonable accommodations, should 

notify the Contact Person listed below 

in advance of the meeting. 

The meeting will be closed to the 

public in accordance with the 

provisions set forth in sections 

552b(c)(4) and 552b(c)(6), Title 5 U.S.C., 

as amended. The grant applications and 

the discussions could disclose 

confidential trade secrets or commercial 

property such as patentable material, 

and personal information concerning 

individuals associated with the grant 

applications, the disclosure of which 

would constitute a clearly unwarranted 

invasion of personal privacy. 

Name of Committee: National Arthritis and 

Musculoskeletal and Skin Diseases Advisory 

Council. 

Date: September 5, 2018. 

Open: 8:30 a.m. to 12:00 p.m. 

Agenda: To discuss program policies and 

issues. 

Place: National Institutes of Health, 

Building 31, Rm: 6C10, 31 Center Drive, 

Bethesda, MD 20892. 

Closed: 1:00 p.m. to 5:00 p.m. 

Agenda: To review and evaluate grant 

applications. 

Place: National Institutes of Health, 

Building 31, Rm: 6C10, 31 Center Drive, 

Bethesda, MD 20892. 

Contact Person: Melinda Nelson, Acting 

Director, National Institute of Arthritis and 

Musculoskeletal and Skin Diseases, Grants 

Management Branch, 45 Center Drive, Room 

5A49, Bethesda, MD 20892, (301) 594–3535, 

mn23z@nih.gov. 

Any interested person may file written 

comments with the committee by forwarding 

the statement to the Contact Person listed on 

this notice. The statement should include the 

name, address, telephone number and when 

applicable, the business or professional 

affiliation of the interested person. 

In the interest of security, NIH has 

instituted stringent procedures for entrance 

onto the NIH campus. All visitor vehicles, 

including taxicabs, hotel, and airport shuttles 

will be inspected before being allowed on 

campus. Visitors will be asked to show one 

form of identification (for example, a 

government-issued photo ID, driver’s license, 

or passport) and to state the purpose of their 

visit. 

(Catalogue of Federal Domestic Assistance 

Program Nos. 93.846, Arthritis, 

Musculoskeletal and Skin Diseases Research, 

National Institutes of Health, HHS) 

Dated: August 3, 2018. 

Sylvia L. Neal, 

Program Analyst, Office of Federal Advisory 

Committee Policy. 

[FR Doc. 2018–16975 Filed 8–7–18; 8:45 am] 

BILLING CODE 4140–01–P 

DEPARTMENT OF HEALTH AND 

HUMAN SERVICES 

National Institutes of Health 

National Institute on Minority Health 

and Health Disparities; Notice of 

Closed Meeting 

Pursuant to section 10(d) of the 

Federal Advisory Committee Act, as 

amended, notice is hereby given of the 

following meeting. 

The meeting will be closed to the 

public in accordance with the 

provisions set forth in sections 

552b(c)(4) and 552b(c)(6), Title 5 U.S.C., 

as amended. The grant applications and 

the discussions could disclose 

confidential trade secrets or commercial 

property such as patentable materials, 

and personal information concerning 

individuals associated with the grant 

applications, the disclosure of which 

would constitute a clearly unwarranted 

invasion of personal privacy. 

Name of Committee: National Institute on 

Minority Health and Health Disparities; 

Special Emphasis Panel; Review of R01 

Applications in Response to RFA–MD–18– 

005, ‘‘Youth Violence Prevention 

Interventions’’. 

Date: October 19, 2018. 

Time: 8:00 a.m. to 5:00 p.m. 

Agenda: To review and evaluate grant 

applications (Teleconference). 

Place: National Institutes of Health, 

Gateway Plaza, 7201 Wisconsin Ave, 

Bethesda, MD 20817. 

Contact Person: Deborah Ismond, Ph.D., 

Scientific Review Officer, Division of 

Scientific Programs, National Institute on 

Minority Health and Health Disparities, 

National Institutes of Health, 7201 Wisconsin 

Ave., Suite 525, Bethesda, MD 20814, (301) 

594–2704, ismonddr@mail.nih.gov. 


sradovich on DSK3GMQ082PROD with NOTICES